Ingenix

Warsaw, Poland

Ingenix is a healthcare startup specializing in the development of a proprietary multimodal artificial intelligence (AI) foundation model that simulates clinical trial solutions. The company's innovative model integrates biological and medical knowledge across various modalities, including text, graphics, bioimaging, 3D structures, sequences, and time series, utilizing a chain-of-thought prompting approach. Ingenix's AI model operates at multiple scales, from molecular to population levels, enabling rapid predictions and insights into complex human biology, which is essential for effective drug development and tackling the complexities of multimodal biological systems. Their platform allows clinical investigators to query the AI using natural language, gaining insights into factors driving predictions regarding clinical trial outcomes, including clinical endpoint values and adverse events. Ingenix aims to bridge the gap between top scientists and the pharmaceutical industry, ultimately benefiting millions of people worldwide by advancing AI-powered drug discovery and development.